Cellectis S.A. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.98 | $56.28 M | -5.86 | 2 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $50.71 | $3.53 B | -11.86 | 290 | $4.01 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 DMAC
|
DiaMedica Therapeutics Inc. | $4.17 | $97.19 M | -4.74 | 18 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $4.97 | $258.33 M | -17.08 | 9 | $0 |
 ERYP
|
ERYTECH Pharma S.A. | $0.78 | $47.38 M | -78 | 49 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $9.36 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.17 | $243.38 M | -1.59 | 129 | $0 |
 GNFT
|
Genfit S.A. | $5.70 | $269.95 M | -8.62 | 169 | $28.57 M |
 HCWB
|
HCW Biologics Inc. | $0.51 | $39.35 M | -1.37 | 45 | $2.84 M |
 INBX
|
Inhibrx Biosciences, Inc. | $15.55 | $241.02 M | -1.44 | 166 | $1.80 M |
 IPHA
|
Innate Pharma S.A. | $2.19 | $233.63 M | -28.9 | 168 | $51.90 M |
 KYMR
|
Kymera Therapeutics, Inc. | $48.69 | $2.02 B | -13.13 | 181 | $78.59 M |
 KZR
|
Kezar Life Sciences, Inc. | $0.54 | $49.85 M | -0.49 | 58 | $7.00 M |
 LIAN
|
LianBio | $0.32 | $34.47 M | -0.39 | 163 | $0 |
 NBSE
|
NeuBase Therapeutics, Inc. | $0.38 | $1.42 M | -0.02 | 37 | $0 |
 NRIX
|
Nurix Therapeutics, Inc. | $23.06 | $930.10 M | -5.89 | 284 | $76.99 M |
 PASG
|
Passage Bio, Inc. | $0.68 | $73.04 M | -0.77 | 58 | $0 |
 RGNX
|
REGENXBIO Inc. | $10.80 | $693.52 M | -2.4 | 344 | $90.24 M |
 SGTX
|
Sigilon Therapeutics, Inc. | $22.47 | $56.22 M | -1.52 | 62 | $12.94 M |
 SLNO
|
Soleno Therapeutics, Inc. | $49.13 | $1.66 B | -22.01 | 33 | $0 |
 STTK
|
Shattuck Labs, Inc. | $3.87 | $333.81 M | -3.64 | 75 | $1.66 M |